missing translation for 'onlineSavingsMsg'
Få mere at vide

STEMCELL Technologies SB202190

Artikelnummer. 17100102
Encompass_Preferred
Skift visning
Klik for at se tilgængelige muligheder
Quantity:
10 mg
25 mg
Pakningsstørrelse:
10mg
25mg
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Artikelnummer. Quantity unitSize
17100102 10 mg 10mg
17110102 25 mg 25mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
Denne vare kan ikke returneres. Se returpolicy
Artikelnummer. 17100102 Leverandør STEMCELL Technologies Leverandørnr. 72632

Please to purchase this item. Need a web account? Register with us today!

Denne vare kan ikke returneres. Se returpolicy

p38 MAPK inhibitor

  • SB202190 is a selective, potent, cell-permeable inhibitor of p38 MAP kinases, inhibiting p38α (SAPK2A, MAPK14) and p38β (SAPK2B, MAPK11) with IC50 values of 50 and 100 nM, respectively (Davies et al.; Jiang et al.) As a pyridinyl imidazole inhibitor, SB202190 directly binds p38 MAP kinases in the ATP binding pocket (Fox et al.)
  • Improves the self-renewal ability of neural stem cells from NPC1-deficient mice (Yang et al.)
  • Blocks adiponectin-mediated proliferation of hematopoietic stem cells (DiMascio et al.)
  • Reduces BMP3-mediated proliferation of C3H10T1/2 mesenchymal stem cells (Stewart et al.)
  • Induces cardiomyocyte differentiation from human embryonic stem cells (Graichen et al.)

Tekniske data

CAS 152121-30-7
Quantity 10 mg
Molecular Formula C20H14FN3O
Purity ≥98%
Produkttitel
Vælg et problem

Ved at klikke på Send, anerkender du, at du kan blive kontaktet af Fisher Scientific med hensyn til den feedback, du har givet i denne formular. Vi deler ikke dine oplysninger til andre formål. Alle angivne kontaktoplysninger skal også vedligeholdes i overensstemmelse med vores Privatlivspolitik.